Collidion Patents – Insights & Stats (Updated 2023)

Collidion has a total of 76 patents globally, out of which 13 have been granted. Of these 76 patents, more than 89% patents are active. United States of America is where Collidion has filed the maximum number of patents, followed by Singapore and Korea (South). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Collidion.

Collidion was founded in the year 2015. The Company operates as a pharmaceutical company. The Company focuses on improving the future of healthcare sector through the acquisition, licensing, development, and commercialization of drugs and medical devices.

Do read about some of the most popular patents of Collidion which have been covered by us in this article and also you can find Collidion patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Collidion patent portfolio.

How many patents does the founder and the CEO of Collidion have?

The founder William Watson has 0 patent and CEO Hoji Alimi has 0 patent.

How many patents does Collidion have?

Collidion has a total of 76 patents globally. These patents belong to 23 unique patent families. Out of 76 patents, 68 patents are active.

How Many Patents did Collidion File Every Year?

Collidion Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCollidion Applications FiledCollidion Patents Granted
202333
202275
2021122
2020252
2019151
201814

How many Collidion patents are Alive/Dead?

Collidion Patent Portfolio

 How Many Patents did Collidion File in Different Countries?

Collidion Worldwide Patent Filing

Countries in which Collidion Filed Patents

CountryPatents
United States Of America12
Singapore6
Korea (South)5
India5
Brazil5
Canada5
Europe5
South Africa5
Australia5
Israel5
China4
Mexico3
Hong Kong (S.A.R.)2
Denmark1
Jordan1

Where are Research Centres of Collidion Patents Located?

The Research Centre for all the Collidion patents is the United States of America.

10 Best Collidion Patents

WO2019006217A1 is the most popular patent in the Collidion portfolio. It has received 10 citations so far from companies like Clinical Health Technologies Ltd, Toyo Shinyaku Co., Ltd. and Brill Engines S L.

Below is the list of most cited patents of Collidion:

Publication NumberCitation Count
WO2019006217A110
CN111032060A6
KR2020034722A4
US10412968B23
US20190099336A12
US11272710B21
US20200375189A11
US20190117534A11
WO2019140408A11
WO2019070920A11

What Percentage of Collidion US Patent Applications were Granted?

Collidion (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 57.14%.

Below are the key stats of Collidion patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Collidion?

Law FirmTotal ApplicationsSuccess Rate
Ultimatedge Ip Law Group P C1257.14%

What are Collidion’ key innovation segments?

What Technologies are Covered by Collidion?

The chart below distributes patents filed by Collidion in different countries on the basis of the technology protected in patents. It also represents the markets where Collidion thinks it’s important to protect particular technology inventions.

R&D Focus: How has Collidion’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Collidion?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.